We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1966 | -1.61147540984 | 12.2 | 12.45 | 10.52 | 41716 | 11.4000374 | CS |
4 | -1.6966 | -12.3839416058 | 13.7 | 14.18 | 10.52 | 32333 | 12.46600245 | CS |
12 | -0.7766 | -6.07668231612 | 12.78 | 15.47 | 10.52 | 28350 | 13.27864875 | CS |
26 | -4.6066 | -27.7338952438 | 16.61 | 18.15 | 10.52 | 31333 | 14.15186393 | CS |
52 | 1.4534 | 13.7763033175 | 10.55 | 21.44 | 8 | 36146 | 14.12852366 | CS |
156 | -12.6266 | -51.2651238327 | 24.63 | 26.27 | 6.8241 | 61079 | 12.53375809 | CS |
260 | 7.0034 | 140.068 | 5 | 128 | 3.262 | 125064 | 33.19149143 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions